MS Pharma
Stage
Unattributed - II | AliveTotal Raised
$95MLast Raised
$45M | 5 yrs agoLatest MS Pharma News
Apr 17, 2020
Posted : 2020-04-17 15:22 Updated : 2020-04-17 15:22 Kim Kyu-jin, fourth from left, CEO of MS Pharma, and Lee Jong-eun, fourth from right, CEO of DNA LINK, pose after signing a strategic memorandum of understanding on the export of COVID-19 test kits, Tuesday. Under the agreement, MS Pharma, a Korean medical equipment company, will be in charge of selling two types of COVID-19 test kits developed by biotech firm DNA LINK. MS Pharma recently signed a contract to export 7 million test kits to Argentina.
MS Pharma Web Traffic
MS Pharma Rank
What is MS Pharma's latest funding round?
MS Pharma's latest funding round is Unattributed - II.
How much did MS Pharma raise?
MS Pharma raised a total of $95M.
Who are the investors of MS Pharma?
Investors of MS Pharma include International Finance Corporation and European Bank for Reconstruction and Development (EBRD).
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.